Discover Research Beta

Browse peer-reviewed articles from Medwin Publishers' open access journals.

Clear Filters

Showing 1–4 of 4 articles

"Yoosakul E" ×
BEBA Research Article Dec 29, 2021
Bioequivalence and Pharmacokinetics of Carvedilol (6.25 and 12.5 Mg Tablets) in Healthy Thai Volunteers
Supasena W, Teerawonganan P, Vattanarongkup J, Yoosakul E, Manamuti C, Saeaue L, Karachot B, Khaowroongrueng V*, Techatanawat I, Puranajoti P and Surawattanawan P

The Government Pharmaceutical Organization (GPO) had developed the generic products of carvedilol 12.5 and 6.25 mg tablets as low-cost alternatives for patients and physicians to …

Carvedilol 4′-hydroxyphenyl Carvedilol β-Blocker
BEBA Research Article Aug 10, 2021
Comparative Bioequivalence Studies of Two Metformin Extended- Release Formulations in Healthy Thai Volunteers
Sunhem A, Yoosakul E, Seeduang C, Duereh M, Teerawonganan P, Saeaue L, Karachot B, Khaowroongrueng V*, Techatanawat I, Rojanawiwat A and Surawattanawan P

Metformin is a first-line treatment for type 2 diabetic mellitus commonly used as a monotherapy or in a combination with other antidiabetic drugs. To control blood glucose levels,…

Metformin Bioequivalence Pharmacokinetic
BEBA Research Article Feb 22, 2021
Bioequivalence of Oseltamivir Phosphate 6 mg/mL Powder for Oral Suspension Formulations in Healthy Thai Volunteers under Fasting Conditions
Yoosakul E, Vattanarongkup J, Kunsa-ngiem S, Suthepakul N, Karachot B, Khaowroongrueng V*, Techatanawat I, Puranajoti P and Surawattanawan P

Oseltamivir is an oral antiviral of choice indicated for treatment and prophylaxis of influenza A and B infections. Oseltamivir is an inactive prodrug of oseltamivir carboxylate, …

Oseltamivir Bioequivalence Pharmacokinetics
BEBA Research Article Jul 10, 2020
Pharmacokinetics and Bioequivalence of Methylphenidate Hydrochloride 10 mg Immediate-Released Tablets in Healthy Thai Volunteers under Fasting Conditions
Khaowroongrueng V*, Sunhem A, Yoosakul E, Saeaue L, Karachot B, Techatanawat I, Rojanawiwat A and Surawattanawan P

Methylphenidate is a central nervous system stimulant indicated for attention deficit hyperactivity disorder (ADHD) and narcolepsy. Methylphenidate GPO® had been developed as a ge…

Methylphenidate Bioequivalence Pharmacokinetic